BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Loustaud-Ratti V, Debette-Gratien M, Jacques J, Alain S, Marquet P, Sautereau D, Rousseau A, Carrier P. Ribavirin: Past, present and future. World J Hepatol 2016; 8(2): 123-130 [PMID: 26807208 DOI: 10.4254/wjh.v8.i2.123]
URL: https://www.wjgnet.com/1948-5182/full/v8/i2/123.htm
(401) (327) (0) (0) (8) (7014) (70)
Number Citing Articles
1
Joshua Casaos, Sakibul Huq, Tarik Lott, Raphael Felder, John Choi, Noah Gorelick, Michael Peters, Yuanxuan Xia, Russell Maxwell, Tianna Zhao, Chenchen Ji, Thomas Simon, Julie Sesen, Sarah J. Scotland, Richard E. Kast, Jeffrey Rubens, Eric Raabe, Charles G. Eberhart, Eric M. Jackson, Henry Brem, Betty Tyler, Nicolas Skuli. Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors. Oncotarget 2018; 9(8) doi: 10.18632/oncotarget.23883
2
Vishvanath Tiwari. Denovo designing, retrosynthetic analysis, and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2. Biology Open 2020;  doi: 10.1242/bio.054056
3
Vishvanath Tiwari. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus. International Journal of Biological Macromolecules 2021; 171 doi: 10.1016/j.ijbiomac.2020.12.223
4
Oumaima Gatri, Thierry Roisnel, Marie Cordier, Vincent Dorcet, Mohamed Lotfi Efrit, Cédric Fischmeister. Thiocarbamoylimidates as Precursors of New 5‐Amino‐1,2,4‐Triazole and Oxadiazole Derivatives In Silico Prediction of Absorption, Distribution, Metabolism, and Excretion Parameters. ChemPlusChem 2025; 90(12) doi: 10.1002/cplu.202500516
5
Alina Tanase, Aniko Manea, Alexandra Denisa Scurtu, Lavinia Melania Bratu, Doina Chioran, Alina Dolghi, Iren Alexoi, Hazzaa AAbed, Voichita Lazureanu, Cristina Adriana Dehelean. The “Invisible Enemy” SARS-CoV-2: Viral Spread and Drug Treatment. Medicina 2022; 58(2) doi: 10.3390/medicina58020261
6
Adrienne O’Donnell, Nathan Pham, Leandra Battisti, Rachel Epstein, David Nunes, Deirdre Sawinski, Sara Lodi, Chen-Hua Liu. Estimating the causal effect of treatment with direct-acting antivirals on kidney function among individuals with hepatitis C virus infection. PLOS ONE 2022; 17(5) doi: 10.1371/journal.pone.0268478
7
Longping V. Tse, Rita M. Meganck, Rachel L. Graham, Ralph S. Baric. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00658
8
Onur Akyıldırım, Ercan Oguz, Abdülmelik Aras, Adnan Cetin, Fikret Türkan, Ercan Bursal, Murat Beytur, Hilal Medetalibeyoğlu, Haydar Yüksek. Novel 1,2,4-triazole derivatives: Synthesis, structural characterization, antidiabetic, anticholinergic and phase II detoxification activities, cytotoxic evaluation, and molecular docking studies. Journal of Molecular Structure 2026; 1363 doi: 10.1016/j.molstruc.2026.145749
9
Christina Wangen, Andrea Raithel, Julia Tillmanns, Christian Gege, Alexandra Herrmann, Daniel Vitt, Hella Kohlhof, Manfred Marschall, Friedrich Hahn. Validation of nuclear receptor RORγ isoform 1 as a novel host-directed antiviral target based on the modulation of cholesterol levels. Antiviral Research 2024; 221 doi: 10.1016/j.antiviral.2023.105769
10
Julia M. Smyk, Anna Majewska. Favipiravir in the Battle with Respiratory Viruses. Mini-Reviews in Medicinal Chemistry 2022; 22(17) doi: 10.2174/1389557522666220218122744
11
Carina Sperotto Librelotto, Daniel Simon, Ana Paula de Souza, Mário Reis Álvares-da-Silva, Rafael Rodrigues Dihl. Chromosomal instability and cytotoxicity induced by ribavirin: comparative analysis in cell lines with different drug-metabolizing profiles. Drug and Chemical Toxicology 2019; 42(4) doi: 10.1080/01480545.2017.1405970
12
Sabrina D'Agostino, Caitlin Davies, Marissa V Powers, Paul A Clarke. Advances in understanding and targeting eIF4E activity. Biochemical Society Transactions 2025; 53(04) doi: 10.1042/BST20241045
13
Debora Obergfäll, Friedrich Hahn, Jintawee Kicuntod, Christina Wangen, Melanie Kögler, Sabrina Wagner, Benedikt Kaufer, Manfred Marschall. New Assay Systems to Characterize the Broad-Spectrum Antiherpesviral and Non-Herpesviral Activity of Cyclin-Dependent Kinase (CDK) 8 Inhibitors. Pharmaceuticals 2025; 18(10) doi: 10.3390/ph18101560
14
Pablo Zubiaur, Dora Koller, Miriam Saiz‐Rodríguez, Marcos Navares‐Gómez, Francisco Abad‐Santos. Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19). Clinical and Translational Science 2020; 13(6) doi: 10.1111/cts.12866
15
Alexei A. Maslov, Nicholas H. Trageser, Julia V. Kichina, Haya Elamir, Evelyn Gardner, Frances Teaman, Vera Vishwanath, Scott M. Dugas, Anna Bianchi-Smiraglia, Katerina I. Leonova, Katerina V. Gurova, Mikhail A. Nikiforov, Eugene S. Kandel. Inhibitors of De Novo Guanylate Biosynthesis Enhance the Potency of MAPK Cascade Inhibitors Against Colorectal Cancer. International Journal of Molecular Sciences 2025; 26(24) doi: 10.3390/ijms262411959
16
Jing Jin, Wei Xiang, Shuang Wu, Min Wang, Meifang Xiao, Ali Deng. Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer. Biochemical and Biophysical Research Communications 2019; 510(4) doi: 10.1016/j.bbrc.2019.01.117
17
Alexei A. Maslov, Nicholas H. Trageser, Julia V. Kichina, Haya Elamir, Evelyn Gardner, Frances Teaman, Vera Vishwanath, Scott M. Dugas, Johanna Heid, Alexander Y. Maslov, Henry G. Withers, Anna Bianchi-Smiraglia, Katerina I. Leonova, Mikhail A. Nikiforov, Eugene S. Kandel. Inhibition of the RAC/PAK Signaling Axis Enhances the Potency of MAPK Cascade Inhibitors Against Uveal Melanoma. Biomolecules 2025; 15(10) doi: 10.3390/biom15101425
18
Fredmoore Orosco. Pan-viral efficacy profile of ribavirin: quantitative potency and safety landscape across virus families. Pharmacia 2025; 72 doi: 10.3897/pharmacia.72.e159854
19
Elenilson F da Silva, Krist Helen Antunes Fernandes, Denise Diedrich, Jessica Gotardi, Marcia Silvana Freire Franco, Carlos Henrique Tomich de Paula da Silva, Ana Paula Duarte de Souza, Simone Cristina Baggio Gnoatto. New triazole-substituted triterpene derivatives exhibiting anti-RSV activity: synthesis, biological evaluation, and molecular modeling. Beilstein Journal of Organic Chemistry 2022; 18 doi: 10.3762/bjoc.18.161
20
F. A. Khaliullin, E. E. Klen, N. N. Makarova. Thietanyl Protection in the Synthesis of 5-Aryloxy(sulfonyl)-3-bromo-1,2,4-triazoles. Russian Journal of Organic Chemistry 2018; 54(12) doi: 10.1134/S1070428018120242
21
J. Cao, X. Sun, X. Zhang, D. Chen. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma. Clinical and Translational Oncology 2018; 20(6) doi: 10.1007/s12094-017-1786-z
22
Debora Obergfäll, Markus Wild, Mona Sommerer, Malena Barillas Dahm, Jintawee Kicuntod, Julia Tillmanns, Melanie Kögler, Josephine Lösing, Kishore Dhotre, Regina Müller, Christina Wangen, Sabrina Wagner, Quang V. Phan, Lüder Wiebusch, Katarína Briestenská, Jela Mistríková, Lauren Kerr-Jones, Richard J. Stanton, Sebastian Voigt, Friedrich Hahn, Manfred Marschall. Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies. Pharmaceutics 2024; 16(9) doi: 10.3390/pharmaceutics16091238
23
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, Upadhyayula Suryanarayana Murty, Sucheta Banerjee Kurundkar, Debjani Roy, Pankaj Joshi, Dhananjay Sable, Yogendra Kumar Choudhary, Prashant Kesharwani, Amit Alexander. In-line treatments and clinical initiatives to fight against COVID-19 outbreak. Respiratory Medicine 2022; 191 doi: 10.1016/j.rmed.2020.106192
24
Hazael Ramiro Ceja-Gálvez, Francisco Israel Renteria-Flores, Ferdinando Nicoletti, Jorge Hernández-Bello, Gabriela Macedo-Ojeda, José Francisco Muñoz-Valle. Severe COVID-19: Drugs and Clinical Trials. Journal of Clinical Medicine 2023; 12(8) doi: 10.3390/jcm12082893
25
Mohamed Abdel‐Samiee, Gamal Aburaia, Eman Abdelsameea, Sara Fathy, Omar Elshaarawy, Hanan M. Bedair. Solute Carrier Gene Polymorphism (SLC29A1) in Relation to Treatment Outcome and Hematological Changes in Chronic Hepatitis C Patients Treated With Direct Acting Antivirals Plus Ribavirin. Journal of Medical Virology 2025; 97(11) doi: 10.1002/jmv.70692
26
Robert W. Shafer, Guy Boivin, Anita Y. M. Howe, Sunwen Chou. ClinMicroNow. 2023;  doi: 10.1002/9781683674849.mcm0115
27
Pierre Sierocki, Krystal Gaillard, Ruben Arturo Arellano Reyes, Chloé Donnart, Emilie Lambert, Sandrine Grosse, Laurence Arzel, Arnaud Tessier, Jerome Guillemont, Monique Mathé-Allainmat, Jacques Lebreton. Synthesis of novel C-nucleoside analogues bearing an anomeric cyano and a 1,2,3-triazole nucleobase as potential antiviral agents. Organic & Biomolecular Chemistry 2022; 20(13) doi: 10.1039/D1OB02451E
28
Sujit Kumar Debnath, Monalisha Debnath, Rohit Srivastava. Opportunistic etiological agents causing lung infections: emerging need to transform lung-targeted delivery. Heliyon 2022; 8(12) doi: 10.1016/j.heliyon.2022.e12620
29
Frederick Hansen, Michael A. Jarvis, Heinz Feldmann, Kyle Rosenke. Lassa Virus Treatment Options. Microorganisms 2021; 9(4) doi: 10.3390/microorganisms9040772
30
Ran Huang, Qiong Dai, Ruixue Yang, Yi Duan, Qi Zhao, Johannes Haybaeck, Zhihui Yang. A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.817916
31
Omer Basar, Francis Dailey, Erica Dailey, Veysel Tahan, Ebubekir Daglilar. Interferon-Induced Crohn’s Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection. Cureus 2021;  doi: 10.7759/cureus.15568
32
Humzah Iqbal, Bilal Fazal Mehmood, Aalam Sohal, Marina Roytman. Hepatitis E infection: A review. World Journal of Virology 2023; 12(5): 262-271 doi: 10.5501/wjv.v12.i5.262
33
Abdel-moniem S Hassan, Abdo A Elfiky, Alaa M Elgohary. Triple in Silico Targeting of IMPDH Enzyme and RNA-Dependent RNA Polymerase of Both SARS-CoV-2 and Rhizopus Oryzae . Future Microbiology 2024; 19(1) doi: 10.2217/fmb-2023-0103
34
Javed Khan, Anjali Rani, Mohd Aslam, R.S. Maharia, Garima Pandey, Bhaskara Nand. Exploring triazole-based drugs: Synthesis, application, FDA approvals, and clinical trial updates–A comprehensive review. Tetrahedron 2024; 162 doi: 10.1016/j.tet.2024.134122
35
Suyin Ge, Qingqing Zhang, Yonglin Chen, Yizhen Tian, Ruiying Yang, Xu Chen, Fang Li, Baolai Zhang. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation. Toxicology and Applied Pharmacology 2021; 415 doi: 10.1016/j.taap.2021.115450
36
Hala A. Abdulhassan, Basil A. Saleh, Dalal Harkati, Hadjer Khelfaoui, Natalie L. Hewitt, Gamal A. El-Hiti. In Silico Pesticide Discovery for New Anti-Tobacco Mosaic Virus Agents: Reactivity, Molecular Docking, and Molecular Dynamics Simulations. Applied Sciences 2022; 12(6) doi: 10.3390/app12062818
37
Qikai Sun, Quanquan Wang, Wenzhuo Qin, Kaiyu Jiang, Gang He, Ming Joo Koh, Gong Chen. N-glycoside synthesis through combined copper- and photoredox-catalysed N-glycosylation of N-nucleophiles. Nature Synthesis 2024; 3(5) doi: 10.1038/s44160-024-00496-7
38
Songül Boy, Hanife Ardahanlı, Kenan Gören, Sevda Manap, Haydar Yüksek. Novel triazole derivative Mannich bases as potential therapeutic agents: synthesis, in-vitro and in-silico studies. Journal of Molecular Structure 2026; 1375 doi: 10.1016/j.molstruc.2026.146893
39
Tangella Nagendra Prasad, Yeruva Pavankumar Reddy, Poorna Chandrasekhar Settipalli, Vadiga Shanthi Kumar, Eeda Koti Reddy, Shaik Firoj Basha, Shaik Anwar. Synthesis oftransN-Substituted Pyrrolidine Derivatives Bearing 1,2,4- triazole Ring. Current Organic Synthesis 2022; 19(5) doi: 10.2174/1570179419666211230094334
40
Lin Wang, Zheyi Wang, Zhihua Yang, Xingwang Wang, Liping Yan, Jianxiong Wu, Yue Liu, Baohui Fu, Hongtao Yang. Potential common mechanism of four Chinese patent medicines recommended by diagnosis and treatment protocol for COVID-19 in medical observation period. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.874611
41
F Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, T Lott, R Felder, S J Scotland, T S K Eisinger-Mathason, H Brem, B Tyler, N Skuli. Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic. Oncogene 2017; 36(21) doi: 10.1038/onc.2016.457
42
Jorge A. Soto, Ricardo A. Loaiza, Sebastián Echeverría, Robinson A. Ramírez, Alexis M. Kalergis. Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants. Expert Opinion on Pharmacotherapy 2023; 24(10) doi: 10.1080/14656566.2023.2213433
43
Jianguo Chen, Xiaoming Xu, Junjun Chen. Clinically relevant concentration of anti-viral drug ribavirin selectively targets pediatric osteosarcoma and increases chemosensitivity. Biochemical and Biophysical Research Communications 2018; 506(3) doi: 10.1016/j.bbrc.2018.10.124
44
Debosmita Sanyal, Binay Chaubey. RNAi-mediated inhibition of SARS-CoV-2: applications and challenges. Future Virology 2024; 19(2-4) doi: 10.2217/fvl-2023-0169
45
Lautaro A. M. Giaimo, Leticia Lafuente, Romina N. Fernández Varela, Matías L. Nóbile, Adolfo M. Iribarren, Elizabeth S. Lewkowicz. Synthesis of 4‐Iodoimidazole Nucleosides: A Biocatalyzed Whole Cell Approach. European Journal of Organic Chemistry 2025; 28(7) doi: 10.1002/ejoc.202400950
46
Gabriella Verucchi, Pierluigi Viale, Rita Mancini, Matteo Rinaldi, Matteo Conti, Lorenzo Badia, Viola Guardigni. Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals. World Journal of Hepatology 2017; 9(34): 1270-1277 doi: 10.4254/wjh.v9.i34.1270
47
Giuseppe M Marcello, Kali A Holder, Sara Hallager, Benjamin B Norton, Kay A Backues, Anna E Tyler, Ayo Zeitlin, Evan Murray-Hiteshew, Suzan Murray. Intralesional application of ribavirin in two American flamingos (Phoenicopterus ruber) with poxvirus infection. Journal of Comparative Pathology 2023; 201 doi: 10.1016/j.jcpa.2022.11.004
48
Robert W. Shafer, Guy Boivin, Anita Y. M. Howe, Sunwen Chou. ClinMicroNow. 2023;  doi: 10.1002/9781683670438.mcm0115
49
Qudus Olajide Lawal, Joseph Okoeguale, Sebastine Oseghae Oiwoh, ThankGod Akhigbe, Reuben Agbons Eifediyi, Sylvanus Akhalufo Okogbenin. Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge. Tropical Medicine and Health 2024; 52(1) doi: 10.1186/s41182-024-00609-0
50
Yuxi Guo, Xuefeng Chen, Pin Gong. Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus. International Journal of Biological Macromolecules 2021; 183 doi: 10.1016/j.ijbiomac.2021.05.139
51
Aditya Upadhyay, Awanish Kumar, Monu Verma. Pathogenic Viruses and Armamentarium Design. 2024;  doi: 10.1016/B978-0-443-15241-2.00005-3
52
Anirudh Pratap Singh Raman, Mohd. Aslam, Amardeep Awasthi, Anas Ansari, Pallavi Jain, Kashmiri Lal, Indra Bahadur, Prashant Singh, Kamlesh Kumari. An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential. Molecular Diversity 2025; 29(1) doi: 10.1007/s11030-024-10858-0
53
Sushmita Patra, Rout George Kerry, Ganesh Kumar Maurya, Bijayananda Panigrahi, Swati Kumari, Jyoti Ranjan Rout. Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.02098
54
Meijun Lu, Qing-Bin Lu, John F. Honek. Squarate-based carbocyclic nucleosides: Syntheses, computational analyses and anticancer/antiviral evaluation. Bioorganic & Medicinal Chemistry Letters 2017; 27(2) doi: 10.1016/j.bmcl.2016.11.058
55
Zhihua Hu, Lanfang Zhen, Qin Li, Qi Han, Qinquan Hua. Ribavirin sensitizes nasopharyngeal carcinoma to 5-fluorouracil through suppressing 5-fluorouracil-induced ERK-dependent-eIF4E activation. Biochemical and Biophysical Research Communications 2019; 513(4) doi: 10.1016/j.bbrc.2019.04.053
56
Prateek Kumar, Taniya Bhardwaj, Ankur Kumar, Bhuvaneshwari R. Gehi, Shivani K. Kapuganti, Neha Garg, Gopal Nath, Rajanish Giri. Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study. Journal of Biomolecular Structure and Dynamics 2022; 40(7) doi: 10.1080/07391102.2020.1845976
57
Eric J. Wang, Jay Karri, Nuj Tontisirin, Steven P. Cohen. Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms. The Korean Journal of Pain 2023; 36(3) doi: 10.3344/kjp.23129
58
Xiaoxi Mao, Haijing Zhou, Xiaotian Wang, Enguang Jiao, Meng Gao, Kunhua Wang, Meili Guan, Liangmin Ning, Min Fu, Wei Chen. Biomass-derived porous carbon based molecularly imprinted polymers with multi-boronic acid sites for capture of ribavirin from water samples. Colloid and Polymer Science 2026; 304(1) doi: 10.1007/s00396-025-05538-w
59
Ehab S El Desoky, Alaa T Abdelhafez, Jessica Cusato, Sherif I Kamel, Abeer MR Hussein, Amedeo De Nicolo, Giovanni Di Perri, Antonio D'Avolio. The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin‐induced anaemia in chronic hepatitis C Egyptian patients. Clinical and Experimental Pharmacology and Physiology 2017; 44(9) doi: 10.1111/1440-1681.12786
60
Vijayakumar Rajendran, Saravanan Kandasamy, Ankita Gupta, Killivalavan Asaithambi, Ashish Runthala, Jagannathan Selvaraj, Shivanandappa Kukkaler Channappa. Drugs and a Methodological Compendium. 2023;  doi: 10.1007/978-981-19-7952-1_15
61
Eloi R Verrier, Amélie Weiss, Charlotte Bach, Laura Heydmann, Vincent Turon-Lagot, Arnaud Kopp, Houssein El Saghire, Emilie Crouchet, Patrick Pessaux, Thomas Garcia, Patrick Pale, Mirjam B Zeisel, Camille Sureau, Catherine Schuster, Laurent Brino, Thomas F Baumert. Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets. Gut 2020; 69(1) doi: 10.1136/gutjnl-2018-317065
62
Sandip N. Badeliya, Ishan I. Panchal, Bibhuranjan Panigrahi, C. N. Patel. In Silico Analysis, Synthesis, and Biological Evaluation of Triazole Derivatives as H1 Receptor Antagonist. Current Drug Discovery Technologies 2021; 18(4) doi: 10.2174/1568009620666200421082221
63
Ojasvi Gupta, Tathagata Pradhan, Gita Chawla. An updated review on diverse range of biological activities of 1,2,4-triazole derivatives: Insight into structure activity relationship. Journal of Molecular Structure 2023; 1274 doi: 10.1016/j.molstruc.2022.134487
64
Jan Rahmig, Arne Grey, Marco Berning, Jochen Schaefer, Martin Lesser, Heinz Reichmann, Volker Puetz, Kristian Barlinn, Timo Siepmann. Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report. BMC Neurology 2020; 20(1) doi: 10.1186/s12883-020-01952-5
65
Mohammad Amin Abbasi, Ehsan Rikhtegar, Shahin Keshtkar Rajabi. A Patient with Brucella with initial Manifestations similar to Crimean Congo Fever. Journal of Research in Applied and Basic Medical Sciences 2023; 9(4) doi: 10.61186/rabms.9.4.229
66
Michael H. J. Rhodin, Nicole V. McAllister, Jonathan Castillo, Sarah L. Noton, Rachel Fearns, In Jong Kim, Jianming Yu, Thomas P. Blaisdell, Joseph Panarese, Brian C. Shook, Yat Sun Or, Bryan Goodwin, Kai Lin, Mark Krystal. EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model. PLOS Pathogens 2021; 17(3) doi: 10.1371/journal.ppat.1009428
67
Asmaa Gomaa, Imam Waked. Direct-Acting Antivirals against Hepatitis C. 2026;  doi: 10.1016/B978-0-443-41363-6.00012-3
68
Ruben Vardanyan, Gayane Vardanyan. Synthesis of Best-Seller Drugs. 2026;  doi: 10.1016/B978-0-443-51186-8.00010-5
69
Liang Liu, Sixun Guo, Chunli Che, Quanming Su, Deqiu Zhu, Xin Hai. Improved HPLC method for the determination of ribavirin concentration in red blood cells and its application in patients with COVID‐19. Biomedical Chromatography 2022; 36(7) doi: 10.1002/bmc.5370
70
DongHoon Yu, Sabrina Wagner, Martin Schütz, Yeejin Jeon, Mooyoung Seo, Jaeseung Kim, Nadine Brückner, Jintawee Kicuntod, Julia Tillmanns, Christina Wangen, Friedrich Hahn, Benedikt B. Kaufer, Frank Neipel, Jan Eickhoff, Bert Klebl, Kiyean Nam, Manfred Marschall. An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics 2024; 16(2) doi: 10.3390/pharmaceutics16020158
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.